( July 23, 2026, 11:20 AM EDT) -- PENSACOLA, Fla. — The manufacturers of Depo-Provera, a long-lasting injectable contraceptive that allegedly caused women to develop intracranial meningiomas, a type of brain tumor, recommended three cases to serve as replacement pilot cases in the multidistrict litigation in a Florida federal court after the parties have reached a settlement agreement to resolve all cases that “meet the eligibility criteria agreed to by the Parties”; the women whose cases were suggested responded with varying degrees of opposition to the designation (In Re:  Depo-Provera [Depot Medroxyprogesterone Acetate] Products Liability Litigation, No. 25-3140, N.D. Fla.)....